by massive structural and functional changes of skeletal muscle tissue, leading to terminal muscle failure. We recently generated a novel genetically engineered pig model reflecting pathological hallmarks of human DMD better than the widely used mdx mouse. To get insight into the hierarchy of molecular derangements during DMD progression, we performed a proteome analysis of biceps femoris muscle samples from 2-day-old and 3-month-old DMD and wild-type (WT) pigs. The extent of proteome changes in DMD vs. WT muscle increased markedly with age, reflecting progression of the pathological changes. In 3-month-old DMD muscle, proteins related to muscle repair such as vimentin, nestin, desmin and tenascin C were found to be increased, whereas a large number of respiratory chain proteins were decreased in abundance in DMD muscle, indicating serious disturbances in aerobic energy production and a reduction of functional muscle tissue. The combination of proteome data for fiber type specific myosin heavy chain proteins and immunohistochemistry showed preferential degeneration of fast-twitch fiber types in DMD muscle. The stage-specific proteome changes detected in this large animal model of clinically severe muscular dystrophy provide novel molecular readouts for future treatment trials.
Duchenne muscular dystrophy (DMD; OMIM reference 310200) affects 1 in 3,600-6,000 live male births and is caused by mutations (mainly large genomic deletions) in the X-linked dystrophin gene (DMD). The absence of the essential muscle protein dystrophin (DMD) results in progressive muscle degeneration and wasting. Most patients are diagnosed around 5 years of age and are wheelchair-bound before their teens. Without intervention, the mean age at death is around 19 years (reviewed in ref. 1) . Though no curative treatment for DMD is currently available, several promising genetic approaches are under development (reviewed in ref. 2) .
Different animal models have been used to dissect disease mechanisms of DMD and to test therapeutic strategies (reviewed in refs [3] [4] [5] . The most widely used animal model of DMD is the mdx mouse which has a nonsense mutation in exon 23 of the Dmd gene. In addition, several other strains with different Dmd mutations, including a targeted deletion of exon 52 6 , have been developed (reviewed in ref. 7) . Recent studies demonstrated the feasibility of exon skipping 8 and gene-editing approaches in the mdx mouse [9] [10] [11] . Skeletal muscle samples of mdx mice have been extensively studied by holistic profiling at the transcriptome [12] [13] [14] [15] [16] and proteome levels [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] to unravel molecular derangements caused by dystrophin deficiency and to assess the consequences of different treatment strategies at a molecular level. Early proteome studies of mdx hindlimb muscles used two-dimensional gel electrophoresis and mass spectrometry to identify differentially , suggesting defective energy metabolism as a hallmark of the disease. GRMD cranial sartorius muscle displayed increased levels of myotrophin and spectrin as compared to age-matched normal dogs, providing a possible explanation for the relative hypertrophy and cytoskeletal stability of this particular muscle in GRMD 35 .
A drawback of this model is that the phenotype is highly variable (reviewed in refs 5 and 36), possibly caused by epigenetic effects and modifier genes 37 .
We recently generated a tailored pig model of DMD, which is deficient of DMD exon 52 and thus resembles a frequent mutation in human DMD 38 . DMD pigs lack dystrophin in skeletal muscles and show clinical signs of a severe myopathy, including elevated serum creatine kinase levels, progressively impaired mobility and muscle weakness, and a maximum life expectancy of 3 months due to respiratory failure. While heart muscle samples of DMD pigs did not show any severe pathology, histological examination of skeletal muscles and diaphragm revealed excessive fiber size variation, numerous large rounded hypertrophic fibers, branching fibers and fibers with central nuclei, as well as segmentally necrotic fibers, hypercontracted fibers and groups of small regenerating muscle fibers. These lesions were associated with interstitial fibrosis and mononuclear inflammatory cell infiltration, mimicking the hallmarks of the human disease. The severity and extent of these alterations progressed with age 38 . Morphometric analyses of biceps femoris muscle samples revealed that the mean minimal Feret's diameter of muscle fibers was 34% and 55% reduced in 2-day-old and 3-month-old DMD pigs as compared to age-matched wild-type (WT) pigs. Furthermore, the proportion of muscle fiber profiles with centrally located nuclear profiles was doubled in 2-day-old DMD pigs and was increased by more than 20-fold in 3-month-old DMD pigs compared to age-matched WT controls, indicating a rapidly progressing DMD pathology 38 . The present study used this unique and well-characterized set of samples to identify progressive proteome changes in skeletal muscle of a large animal model of DMD, reflecting genetic, biochemical, histological and clinical hallmarks of the human disease and revealing molecular readouts for the efficacy of future treatment trials.
Results
Overview of identified proteome changes. We performed liquid chromatography tandem mass spectrometry (LC-MS/MS) approach combined with a label free quantification (LFQ) analysis of biceps femoris muscle samples from 2-day-old and 3-month-old DMD and WT pigs. Representative histological sections of the investigated muscle samples from the four groups are shown in Fig. 1A . A progressive muscular dystrophy in DMD pigs and muscle growth by fiber hypertrophy between 2 days and 3 months of age is documented. In total, 8,871 peptides could be identified (PEP value < 0.05) which could be assigned to 1,428 protein groups at a FDR < 0.01. All identified proteins are listed in Supplementary Table 1 . In addition, ten proteins showing no significant abundance alteration between the four groups are listed in Supplementary Table 2 . These proteins may be used as standards and loading controls for future quantitative experiments with biceps femoris samples of the pig DMD model.
Hierarchical clustering of LFQ values clearly separated the four groups, formed by genotype × age, with age being the higher level clustering factor (Fig. 1B) . The numbers of significant (adjusted p-value < 0.05; log2-fold change > |0.6|) protein abundance changes are shown in Fig. 1C . In both, DMD and WT pigs, major age-dependent changes of the biceps femoris muscle proteome profile were observed, but the concordance of Scientific RepoRts | 6:33362 | DOI: 10.1038/srep33362 these changes between the two genotypes was limited (Fig. 1D) . In both age groups, a large number of proteome differences between DMD and WT pigs were revealed, but the overlap of differentially abundant proteins was small (Fig. 1E) . Differences in the abundance of selected proteins were verified by Western blot analysis (see Supplementary Fig. 1 ). (A) Histology of biceps femoris muscle in WT versus DMD pigs at 2 days and 3 months of age. Note the variation in fiber diameter, rounded fibers, fibers with internalized central nuclei (arrows), and muscle fiber necrosis (*) in DMD pigs. Between 2 days and 3 months of age, there is a pronounced increase in the diameter of muscle fibers in both groups, indicating muscle growth by fiber hypertrophy. Plastic (GMA/MMA) sections, hematoxylin and eosin (H&E) staining; bars = 100 μ m. (B) Hierarchical clustering of label free quantitation (LFQ) values clearly separates four groups according to age (2 days vs. 3 months) and genotype (DMD vs. WT). (C) Numbers of differentially abundant proteins between genotypes within age (horizontal arrows) and between ages within genotype (vertical arrows). Differences were considered to be significant at an adjusted p-value < 0.05 and a log2-fold change > |0.6|. Numbers of proteins with significantly increased (red) and decreased (green) abundance between the group at an arrowhead and the group at the end of the respective arrow are shown. (D) Numbers of significant age-related protein abundance differences in WT and DMD pigs. Note that there is only a small overlap of age-related proteome changes between the two genotypes. (E) Numbers of significant protein abundance differences between DMD and WT pigs at the age of 2 days and 3 months. Note that there is only a small overlap of proteome changes induced by dystrophin deficiency in the two age classes.
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Age-dependent proteome changes in WT and DMD pigs. In WT pigs, the marked muscle growth between day 2 and month 3 by fiber hypertrophy (Fig. 1A) was associated with abundance changes in a large number of proteins. The list of age-dependent proteome changes in WT muscle is given in Supplementary Tables 3a,b and the result of the DAVID 39 analysis is shown in Supplementary Tables 3c-i. The most enriched ontology clusters of proteins with an age-related abundance increase were related to muscle contraction (17 proteins, Enrichment Score: 18.1), and glycolysis and/or glucose metabolic processes (14 proteins, Enrichment Score: 10.7). Proteins which showed an age-dependent decrease in abundance were mainly related to translation (50 proteins, Enrichment Score: 33.2), RNA processing (33 proteins, Enrichment Score: 5.0), and mRNA stability and posttranscriptional regulation of gene expression (14 proteins, Enrichment Score: 4.0).
A detailed list of age-dependent proteome changes in DMD muscle is shown in Supplementary Table 4a,b, results of the DAVID analysis are provided in Supplementary Table 4c-i. The main ontology clusters of proteins increasing in abundance with age were related to glycolysis or carbohydrate catabolic processes (14 proteins, Enrichment Score: 8.5) and muscle contraction/muscle system process (7 proteins, Enrichment Score: 4.0), whereas the major ontology categories of proteins with decreasing abundance were related to energy metabolism (60 proteins Two proteins with higher abundance in DMD muscle were selected for localization studies. Caveolin-1 (CAV1) was predominantly detected in vascular endothelial cells with apparently more stained cell profiles in sections of DMD compared to WT muscle ( Fig. 2A) . USMG5 [up-regulated during skeletal muscle growth 5 homolog (mouse)] was stained in small vesicular and granular structures in the cytoplasm of the majority of WT muscle fibers. In DMD muscle, most fibers exhibited a more diffuse cytoplasmic staining. Furthermore, large hypercontracted DMD muscle fibers with a central nucleus exhibited peripheral accentuated USMG5 staining at the sarcolemma (Fig. 2B) .
DAVID enrichment analysis of the 38 proteins with lower abundance in DMD samples ( Succinate dehydrogenase complex, subunit A (SDHA), which is an important catalytic subunit of succinate-ubiquinone oxidoreductase complex of the mitochondrial respiratory chain showed a 1.7-fold lower abundance in DMD samples and was selected for localization by immunohistochemistry (Fig. 3A) . In muscle sections from 3-month-old WT pigs, clusters of myofibers were identified that exhibited granular cytoplasmic staining, some with peripheral sub-sarcolemmal accentuation. Adjacent fiber groups stained weakly or were apparently negative. Muscle sections from 3-month-old DMD pigs showed very heterogeneous staining with a broad range of staining intensities and patterns within and between fibers. In addition, we performed immunostaining of fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae) (FIS1), an integral protein of the outer mitochondrial membrane, with higher abundance in 3-months-old DMD vs. WT muscle. In WT, FIS1 staining appeared as a granular diffuse cytoplasmic pattern of different intensities. Within a muscle fascicle, predominantly central fibers showed the strongest, adjacent fibers intermediate, and peripheral fibers the weakest staining intensity. In DMD muscle, a broad range of staining intensities of muscle fibers was present without any consistent distribution pattern (Fig. 3B) . Furthermore, immunohistochemistry reflected the markedly increased levels of vimentin (VIM) detected by the LC-MS/MS analysis. Strong VIM immunostaining was observed in small groups of fibers with central nuclei, in some possibly regenerating muscle fibers, and in vascular and interstitial tissue, which was markedly increased in muscle from 3-month-old DMD pigs (Fig. 4) . Fast and slow fiber types are differently affected by dystrophin deficiency in DMD pigs. To address the question if specific muscle fiber types are preferentially affected in the DMD pig model, as suggested by abundance differences of specific myosin heavy chain proteins, we performed immunostaining using antibodies specific for fast-twitch (MHCf) and slow-twitch (MHCs) muscle fibers (Fig. 5A) . In muscle sections from WT pigs of both age groups, the muscle fibers exhibited an inverse staining pattern for MHCf or MHCs. In 3-month-old wild-type muscle, small groups of MHCs fibers were found to be embedded in a majority of MHCf fibers. In DMD muscle, a heterogeneous pattern of MHCf and MHCs muscle fibers was observed with several fibers staining double positive (arrow heads). Our proteomics data for myosin heavy chains allowed further specification of affected fiber types (Fig. 5B) . While there was no significant difference in MYH7 (specific for slow twitch type I fibers) among the groups, MYH2 (specific for fast twitch type IIA fibers) decreased significantly with age in both WT and DMD muscle. The most prominent differences were seen for MYH4 (specific for fast twitch type IIB fibers), which was 4-fold more abundant in 3-month-old vs. 2-day-old WT pigs, whereas in DMD pigs no significant age-related increase was observed, resulting in a markedly reduced MYH4 level in 3-month-old DMD vs. WT muscle. The same was observed for MYH1, a marker of fast twitch type IIX fibers.
Discussion
Proteome profiling of different stages of diseased vs. healthy tissues holds the potential to gain new insights into disease mechanisms and to discover targets and molecular readouts for therapeutic interventions. Due to unavoidable restrictions of systematic muscle sampling in human patients, this approach is not feasible for Duchenne muscular dystrophy patients. Whereas several recent proteome studies of human serum [40] [41] [42] [43] or urine samples 44 reported biomarkers for DMD, systematic proteome studies of dystrophic skeletal muscle are only available for animal models of DMD, primarily the mdx mouse, which has, however, limitations in resemblance of human DMD pathology 31 . Large animal models showing strong phenotypes are the GRMD model 33, 34 and the DMD pig 38 , which was used for this study. Since one of our goals was to provide novel molecular readouts for future treatment trials, we chose the biceps femoris muscle of which corresponding samples can be accessed by biopsy without sacrificing the animal. In addition, quantitative morphological parameters indicative of the severity of muscular dystrophy were available for these samples 38 . As metabolic labeling like SILAC is not applicable for large animal models like the pig, we chose the label free quantification (LFQ) approach 45, 46 . In order to focus on candidates being quickly assessable with routine LC-MS methods, we decided to keep the proteomics workflow as simple as possible without chemical labeling. Instead of pre-fractionation steps, which could prevent reliable LFQ-based protein quantification, we used long chromatographic gradients (440 min) combined with long separation columns (50 cm, 2 μ m beads) to diminish under-sampling. To ensure the reproducibility of our label free quantification experiments, we carefully controlled retention time stability between each run. Although proteomics of skeletal muscle is particularly challenging due to the high abundance of several proteins like myosins, troponins and tropomyosins, we were able to identify 1,428 proteins at a false discovery rate of < 1% which is markedly more than in previous studies investigating non-rodent animal models like the GRMD dog model 34 . The entire dataset was submitted to ProteomeXchange 47 with the dataset identifier PXD002918 and to the Pig PeptideAtlas 48 . In order to verify the reliability of our datasets, we performed hierarchical clustering of the proteome profiles leading to a heat map perfectly reflecting the 4 different groups defined by our 2 genotypes × 2 ages design. Age was the highest clustering factor, indicating major proteome changes in growing skeletal muscle between 2 days and 3 months of age. Importantly, our dataset confirms the previously shown absence of dystrophin in samples from DMD pigs and the up-regulation of utrophin in 3-month-old DMD vs. age-matched WT animals 38 (see Supplementary Tables 5b and 6b ). The comparison of protein abundances between 2-day-old DMD and WT animals reveals early derangements of DMD muscle. Among the proteins more abundant in muscle of 2-day-old DMD animals was caveolin-1 (CAV1), an integral membrane protein with preferred location in caveolae. Proposed functions include lipid transport, membrane traffic, and cell signaling (reviewed in ref. 49 ). In masticatory muscles of mdx mice, CAV1 was associated with blood vessels in areas with regenerating muscle fibers 50 . In vascular endothelial cells, CAV1 was shown to form a complex with dystrophin and endothelial NO synthase 51 . We localized CAV1 in blood vessels of 2-day-old WT and DMD pigs, with an apparent trend of more stained cells in the latter group (see Fig. 2A ).
Another protein with increased abundance in 2-day-old DMD vs. WT pigs was Xin actin-binding repeat-containing protein 1 (XIRP1), a multi-adaptor protein which plays important roles in the assembly and repair of myofibrils and is capable of binding filamin C (FLNC) and the dystrophin-binding protein aciculin (PGM5) 52 . Of interest, FLNC abundance was also increased in muscle samples from 2-day-old DMD vs. WT pigs. The same is true for titin-cap (TCAP, previously termed telethonin), a muscle-specific titin-capping protein which provides structural support to the sarcomere by linking the N-terminus of titin to other z-disc proteins. Collectively, these findings suggest that up-regulation of proteins maintaining the structure of sarcomeres is an early compensatory response to dystrophin deficiency.
Up-regulated during skeletal muscle growth 5 homolog (mouse) (USMG5) was increased in abundance in 2-day-old DMD pigs. USMG5 is a small subunit of the mitochondrial ATP synthase and of the lysosomal V-ATPase. Immunostaining of USMG5 in rat skeletal muscle revealed a higher abundance in highly oxidative than in less oxidative or glycolytic muscle fibers 53 . USMG5 localization in muscle fibers from 2-day-old WT and DMD pigs revealed distinctly different staining patterns, with a clear association of USMG5 to granular and vesicular structures in the cytoplasm of WT muscle cells, and a more diffuse USMG5 staining in most DMD muscle fibers (see Fig. 2B ). Interestingly, a study investigating determinants of disease severity in DMD found 4.7-fold increased USMG5 mRNA levels in muscle biopsies from patients with late vs. early loss of ambulation 54 . Thus, the increase of USMG5 in muscle samples from 2-day-old DMD pigs may represent an early rescue mechanism.
The quantitative analysis of the MS-data from 3-months-old DMD vs. corresponding WT pigs revealed differently abundant proteins from a variety of functional classes.
Human DMD is associated with an increase of connective tissue (fibrosis) as a reparative response to muscle damage and injury 55 , resulting in an accumulation of extracellular matrix proteins. Similarly, the skeletal muscle of the DMD pig model showed an increase of fibrotic tissue ongoing with an increase of transcripts related to proteins of the extracellular matrix 38 . This is in line with our observation that a variety of extracellular matrix proteins were found to be more abundant in the samples of 3-month-old DMD pigs. For instance, we found the proteins collagen type VI alpha 1 (COL6A1, 1.9-fold) and collagen type VI alpha 3 (COL6A3, 2.6-fold) significantly enriched in the muscle of 3-months-old DMD pigs. Both proteins are subunits of collagen VI which is an important component of the muscular extracellular matrix (ECM) and mainly provided by interstitial muscular fibroblasts 56 . An increase of COL6A1 was previously detected in the diaphragm of mdx mice during aging 28 , in diaphragm samples of mdx 20 and mdx-4cv 57 mice, as well as in skeletal muscle samples of mdx compared to WT animals 23, 26 . The importance of muscle collagen VI is reflected by diseases like the Bethlem myopathy and the Ullrich congenital muscular dystrophy caused by mutations of the COL6 genes. Furthermore, it could be demonstrated that collagen VI is a component of the satellite cell niche and important for satellite cell self-renewal and muscle regeneration 58 . The increased abundance of collagen VI in the proteome of the DMD pig may therefore reflect ongoing muscle regeneration. In addition, we found increased levels of collagen type XII alpha 1 (COL12A1, 2.6-fold) in muscle of 3-month-old DMD pigs. Interestingly, a mutation of this gene was also found to be associated with a Bethlem myopathy-like phenotype of patients with absent mutations in the collagen VI genes 59 . Additionally, several intermediate filament (IF) proteins were more abundant in muscle tissue of 3-month-old DMD pigs as compared to the WT animals. Among them were nestin (33-fold), vimentin (9-fold), and desmin (2.5-fold). While nestin is a type IV IF, desmin and vimentin belong to the type III family of IF proteins. During regeneration of injured adult rat muscle, nestin was found to be present in myoblasts and myotubes and to form filaments with vimentin and desmin 60 . For vimentin, abundance alterations were already observed in a variety of proteomics studies analyzing skeletal muscle of mdx mice 20, 21, 23, 26, 30 and from the GRMD model 34 . Additionally, elevated desmin abundances were observed in skeletal muscle 20, 21 and diaphragm 61 of mdx and in diaphragm of mdx-4cv mice 57 . Increased vimentin and desmin abundance in dystrophic muscles was discussed as a compensatory mechanism supporting the structural organization of the sarcomere 62 . Vimentin localization revealed that the marked increase of vimentin in muscle samples from 3-month-old DMD pigs was mainly due to a large proportion of vimentin positive interstitial tissue (see Fig. 4 ). In addition to IF proteins, the extracellular matrix protein tenascin C (TNC), known to be involved in muscle repair 63 , was more abundant in muscle samples from 3-month-old DMD pigs. In mdx mouse muscle, TNC staining was prominent in degenerating/regenerating areas, but absent from undegenerated muscle. TNC was also detected in muscle from DMD boys and DMD dog models, and it was suggested that TNC expression is stimulated by muscle cell degeneration and remains high unless successful regeneration occurs 64 . Taken together, the increased abundance of intermediate filament proteins and of tenascin C in the samples of 3-month-old DMD pig muscle is in line with findings made in other DMD models and may reflect ongoing regeneration of damaged muscle fibers.
Strikingly, many proteins related to energy metabolism were less abundant in muscle samples from 3-month-old DMD pigs compared to age-matched WT controls. Remarkably, reduced abundance of proteins from all respiratory chain complexes was observed pointing to an impaired oxidative energy production in 3-month-old DMD pig muscles. In addition, SDHA showed a deranged staining pattern in DMD compared to WT muscle (Fig. 3A) . This observation in our pig model reflects results of previous proteomics studies analyzing skeletal muscle of mdx mice 21, 22 and GRMD dogs 34 . The decrease of oxidative phosphorylation enzymes may be explained by the relative reduction of functional muscle tissue and an increase of interstitial fibrosis revealed by our morphological findings in DMD pig muscle.
A recent study of mdx mouse muscle showed abnormal localization of subsarcolemmal mitochondria and impaired ATP-generating capacity 65 . A further study investigating isolated muscle mitochondria of 12-week-old mdx and healthy control mice suggested Complex I insufficiency as a reason for impaired mitochondrial ATP production 66 . Since the DMD pig shows more severe symptoms than the mdx mouse and a particularly high number of respiratory chain proteins decreased in abundance, our findings suggest the pig model to be especially suitable to further study DMD related mitochondrial dysfunction.
Beside proteins of the respiratory chain complexes, mitochondrial fission 1 protein (FIS1) is increased in abundance in DMD pig muscle. Mitochondrial fission and fusion are crucial processes determining morphology and dynamics of the mitochondrial network. Furthermore, fission followed by selective fusion segregates dysfunctional mitochondria and allows their removal by autophagy 67 . We found FIS1 more abundant in 3-month-old DMD vs. WT pigs. FIS1 promotes mitochondrial and peroxisomal fission by recruiting the dynamin-related protein, Drp1 (DMN1L) 68 . Besides, FIS1 is supposed to be involved in the fragmentation of the mitochondrial network and its perinuclear clustering 69 . Interestingly, a recent study found increased levels of Drp1 and mitofusin 2 (MFN2, important for mitochondrial fusion) in extensor digitorum longus muscle samples of a utrophin-dystrophin deficient (DKO) mouse model 70 . The authors speculated that increased mitochondrial fission-fusion rates may compensate an elevated energy production in response to a higher demand due to muscle damage and oxidative inefficiency. The localization of FIS1 in muscle sections from 3-month-old DMD pigs (Fig. 3B ) was in line with this hypothesis. Their muscle fibers showed a broad range of staining intensities without any defined pattern, whereas in WT muscle a clear gradient of three staining intensities was apparent in each muscle fascicle, with the strongest staining of fibers in the center and the weakest in the periphery. Strikingly, beside proteins related to energy production, several proteins playing an important role for muscle contraction are altered in abundance in the 3-month-old DMD pigs. Mammalian skeletal muscle tissue consists of different types of muscle fibers. The so called "slow" type I muscle fibers contract slower and with smaller force, but fatigue slower as compared to other muscle fiber types 71, 72 . In contrast, so called "fast" type II muscle fibers contract faster and with higher force 73 , but fatigue earlier 74 . According to molecular properties of their myosin heavy chain (MYH), type II fibers can be subdivided in type IIa fibers containing MYH2 (also known as MyHC-IIa), type IIb fibers with MYH4 (also known as MyHC-IIb), and type IIx fibers with MYH1 (also known as MyHC-2x) 75 . The characteristic myosin heavy chain for type I fibers is MYH7 (also referred to as MyHC-slow). Interestingly, the abundances of these characteristic MYH proteins, were differently altered in the 3-month-old DMD animals. As shown in Fig. 5 , the abundance of MYH7 and MYH2, is not affected by the lack of dystrophin. In contrast, MYH1 and MYH4 were strongly decreased in abundance in DMD muscle. These findings are in line with results from a gastrocnemius muscle proteome study of 6-week-old mdx mice 26 and with those from human DMD patients exhibiting a fast-to-slow fiber type shift with strong decrease of fast glycolytic muscle fibers 76, 77 . This shift might be caused by preferential susceptibility of fast fiber types (especially type IIb) to degeneration in DMD 76 . Since in DMD pig muscle numerous fibers stained positive for both MHCs and MHCf, the increased proportion of slow fibers in DMD muscle may in part also be a result of fiber type shifting.
Conclusions
Our proteome study of the first pig model of DMD revealed a large number of stage specific proteome changes, many of which are in line with findings of previous proteome studies with other well established DMD animal models and thus reflect the relevance of our data and animal model. Additionally, we provide new insights into the nature and time course of molecular derangements of dystrophic muscle. Especially the early alterations of the muscle proteome may be used for evaluation of efficacy of new therapies, such as exon skipping or gene editing, thereby complementing clinical and morphological readouts. Promising results of these novel therapies have been achieved in the mouse model [8] [9] [10] [11] and in preclinical studies performed using the GRMD dog model (reviewed in ref. 5 ). The major advantage of the DMD pig model over the GRMD model is the type of mutation which corresponds to a frequent human DMD mutation. This is important for testing targeted therapies, such as exon skipping 8 or CRISPR/Cas mediated exon deletion [9] [10] [11] . Since the DMD pig shows major pathological hallmarks of human DMD already at an earlier stage, targeted therapies such as exon skipping can be started early after birth to test if the rapid progression of the disease can be -at least partially -prevented. In a large animal model of human disease even intrauterine treatment strategies could be tested. Further evaluation and refinement of these novel therapy approaches in DMD pigs may aid their translation into clinical application.
Methods
Animal model and tissue samples. All animal experiments were carried out in accordance with the German Animal Welfare Act and were approved by the responsible animal welfare authority (District Government of Upper Bavaria, Reference Number 55.2-1-54-2531-86-10). DMD pigs were generated as described before 38 . DMD piglets and age-matched WT controls were euthanized at 2 days and approximately 3 months of age (n = 3 per genotype and age). For this study we focused on samples of biceps femoris, since for future treatment trials corresponding biopsies can be easily performed without sacrificing the animal. Ca. 100 mg of biceps femoris were shock frozen on dry ice, and stored at − 80 °C until further analysis. Additional samples were fixed in neutrally buffered formaldehyde solution (4%) for 24 hours, routinely processed and embedded in paraffin or in plastic [glycol methacrylate and methyl methacrylate (GMA/MMA)] Mass spectrometry. LC-MS/MS was performed on an EASY-nLC 1000 chromatography system (Thermo Scientific, Waltham, MA, USA) connected to an Orbitrap XL instrument (Thermo Scientific). Five μ g of peptides diluted in 0.1% formic acid (FA) were transferred on a trap column (PepMap100 C18, 75 μ m × 2 cm, 3 μ m particles, Thermo Scientific) and separated at a flow rate of 200 nL/min (Column: PepMap RSLC C18, 75 μ m × 50 cm, 2 μ m particles, Thermo Scientific) using consecutive linear gradients from 2% to 25% solvent B (0.1% formic acid, 100% ACN) in 320 min and from 25% to 50% solvent B in 120 min. For data acquisition, a top five data dependent CID method was used. Data were transferred to ProteomeXchange 47 with the dataset identifier PXD002918.
Bioinformatics. MS data were processed, using MaxQuant V1.5.1 45 and the Sus scrofa subset of the UniProt database. For identification, the following parameters were used: i) Enzyme: Trypsin; ii) Mass tolerance precursor: 10 ppm; iii) Mass tolerance MS/MS: 0.8 Da; iv) Fixed modification: Carbamidomethylation of cysteine; v) Variable modifications: acetylation of protein N-terminus and oxidized methionine. FDRs at the peptide and protein level were set to 1%. For label-free quantification (LFQ) 46 the match between runs option was enabled. Hierarchical clustering was performed with the Perseus module of MaxQuant. In case proteins were detected in all replicates of one group, but in no replicate of the other group, the MaxQuant imputation feature was used to allow a statistical evaluation. Further statistics was done with R 79 . A 2-way ANOVA with age and genotype as fixed effects was performed, followed by Tukey Honest Significant Differences post-hoc test to verify differences between the groups. To correct the results of the 2-way ANOVA for multiple testing, we chose a FDR-based approach and calculated the q-value using the R package "qvalue". This approach avoids false positive results while offering a more liberal correction criterion compared to other methods 80 . For the DAVID analysis as well as for the discussion section, we exclusively used proteins showing an abundance alteration of a log2fold > │ 0.6│ and a significance level of < 0.05 after correction for multiple testing. To facilitate a meta-analysis addressing also less prominent abundance alterations, the quantitative values for all identified proteins are listed in Supplementary Morphological analysis and immunohistochemistry. Histological analyses of biceps femoris muscle samples were performed as described previously 38 . Plastic sections (glycol methacrylate/methyl methacrylate, GMA/MMA 82 ) were stained with hematoxylin and eosin (H&E) to show the degree of dystrophy of biceps femoris muscle from 2-day-old and 3-month-old DMD pigs as compared to age-matched WT controls. Immunohistochemistry was performed on paraffin sections (5-7 μ m), using the primary and secondary antibodies listed in Supplementary Table 7 , VECTASTAIN Elite ABC-Peroxidase Kit when using biotinylated secondary antibody, and 3,3′ -diaminobenzidine tetrahydrochloride dihydrate (DAB). Nuclear counterstaining was done with hemalum.
